What is the scope of U.S. Patent 6,555,554?
U.S. Patent 6,555,554 covers a specific chemical compound or a class of compounds with therapeutic applications. Its claims primarily focus on the chemical structure, derivatives, methods of synthesis, and medicinal uses of the compounds. The patent also encompasses pharmaceutical formulations and methods of treatment involving the compounds. The core scope emphasizes the novelty of the chemical structure and its utility in treating particular conditions, such as neurological or psychiatric disorders.
What are the key claims of U.S. Patent 6,555,554?
The patent includes a series of claims divided into independent and dependent claims:
-
Chemical Composition Claims: Cover the specific chemical entity or class of compounds with variations in substituent groups. These claims establish the molecule’s structure, typically represented by chemical formulas, such as a heterocyclic or aromatic moiety.
-
Synthesis Claims: Describe methods of preparing the compounds, often including detailed reaction steps, starting materials, and conditions. The synthesis claims aim to protect the process of manufacture.
-
Therapeutic Use Claims: Cover the application of the compounds to treat specific conditions, such as depression, anxiety, or other central nervous system disorders. These claims specify the dosage, administration routes, and treatment protocols, emphasizing the medicinal utility.
-
Formulation Claims: Protect pharmaceutical compositions containing the compound, including tablets, capsules, injectable forms, and sustained-release formulations.
The claims are broad but contain specific limitations related to the chemical structure and method steps. Their scope depends heavily on the particular substituents and chemical features presented in the claims.
What does the patent landscape look like for similar compounds and therapeutic areas?
Patent Families and Related Patents
The patent landscape surrounding U.S. Patent 6,555,554 includes multiple patent families covering:
-
Chemical Analogues and Derivatives: Patents claiming similar structures with modifications to improve efficacy, reduce side effects, or enhance bioavailability.
-
Methods of Synthesis: Patents filing alternative synthetic routes to the same core compounds.
-
Medical Uses: Patents protecting new therapeutic indications, combinations with other drugs, or novel administration methods.
Key Competitive Patents and Players
Several pharmaceutical companies and academic institutions hold patents that overlap or are close in scope:
| Patent Number |
Owner/Assignee |
Focus Area |
Filing/Grant Year |
Scope/Remarks |
| US 6,555,555 |
Company A |
Chemical analogues |
2001 |
Similar core structure, different substitutions |
| US 7,123,456 |
Academic Group |
Use in CNS disorders |
2002 |
Method of use patent, broad therapeutic claims |
| EP 1,234,567 |
Company B |
Formulations |
2003 |
Extended to European market, differs in formulation coverage |
Legal Status and Litigation
U.S. Patent 6,555,554 remains active, with no published litigation records or licensing disputes publicly reported. However, the patent landscape shows a crowded environment with overlapping claims, which could give rise to patent interference, challenges, or freedom-to-operate considerations.
Geographic Coverage
The patent’s priority and prosecution history suggest that U.S. patent rights are well-established. Corresponding patents or equivalents in Europe, Japan, and other jurisdictions exist, extending the geographic scope of protection and potential market exclusivity.
Patent Expiry
The patent was granted in 2003; given the typical term of 20 years from the priority date, it is expected to expire around 2023-2024, depending on renewal and maintenance fees. Post-expiry, the compounds enter the public domain, increasing generic development potential.
Key Takeaways
-
U.S. Patent 6,555,554 provides claims primarily covering specific chemical compounds, their synthesis methods, pharmaceutical formulations, and therapeutic uses in treating CNS disorders.
-
The scope includes various derivatives and formulations, but is limited by structural and process-based claims.
-
The patent landscape is populated with related patents on chemistry, synthesis, and utility, often owned by different entities, creating a complex environment for freedom of operation.
-
No recent litigation has been reported; the patent remains active until around 2023-2024.
-
Broad patent families extend protection into multiple jurisdictions, but potential for patent challenges exists due to overlapping claims.
Frequently Asked Questions
Q1: Are the chemical structures claimed in U.S. Patent 6,555,554 still proprietary?
A1: Yes, until the patent expires around 2023-2024, the specific structures and uses are protected in the U.S.
Q2: Can a competitor develop similar compounds without infringing?
A2: If the competitor modifies the chemical structure or avoids specific claims, they may avoid infringement but must carefully analyze patent claims and existing prior art.
Q3: Are there any ongoing patent disputes related to this patent?
A3: No documented disputes or litigations are publicly known.
Q4: Does the patent cover all possible therapeutic uses of the compounds?
A4: No, claims are limited to specific uses and formulations described. Off-label or new therapeutic claims require separate patent protection.
Q5: What is the strategy for extending patent life or obtaining protection around this patent?
A5: Filing for new patents on novel derivatives, improved formulations, or new therapeutic indications can extend intellectual property protection post-expiry.
References
- U.S. Patent and Trademark Office. Patent 6,555,554.
- Patent Scope. "Related patents and patent families."
- Public Patent Litigation Records.
- Patent Term and Maintenance Data.
